In clinical microbiology, the accuracy of diagnostic results depends heavily on the quality of the culture media used to grow and identify pathogens. To ensure consistency and reliability, laboratories follow strict quality control (QC) guidelines. The definitive standard for this process is published by the Clinical and Laboratory Standards Institute (CLSI) under the document code .
The fundamental premise of M22-A3 is that retesting commercially prepared microbiological culture media is unnecessary for those media of proven reliability. To achieve this, the standard provides a risk‑based framework that assigns specific quality control (QC) responsibilities.
It established clearer guidelines for incubation conditions during media QC and recommendations for fastidious organisms. Responsibilities Across the Supply Chain
If you are searching for M22-A3 for active laboratory compliance, be aware that standards are updated periodically. clsi m22a3 pdf link
The CLSI M22-A3 standard remains a cornerstone of cost-effective, high-quality clinical microbiology. By distinguishing between exempt and non-exempt culture media, it saves laboratories countless hours of unnecessary testing while preserving strict diagnostic safety margins. Ensure your facility remains compliant and audit-ready by securing an official, authorized PDF link directly through the CLSI portal.
It details what laboratory personnel must check upon receiving media (e.g., sterilization, sterility, and performance testing for non-exempt media).
: The M22-A3 revision expanded the list of media exempt from routine user quality control by 27 additional types, based on low failure rates reported in surveys. Failure Rate Threshold : It established an acceptable failure rate cutoff of In clinical microbiology, the accuracy of diagnostic results
: The document simplified basic protocols for maintaining quality control organisms and updated incubation conditions. Clinical & Laboratory Standards Institute | CLSI Why Standards Like M22-A3 Matter
Always ensure you're accessing documents from reputable sources to guarantee accuracy and legitimacy.
First published on June 20, 2004, this standard replaced the previous version, M22-A2, which was published in December 1996. It was reaffirmed by CLSI in 2018 (noted as M22-A3 (R2018)), signifying that its technical content remains current and valid. As a recognized consensus standard, it was also formally recognized by the U.S. Food and Drug Administration (FDA) on January 14, 2019. The standard contains quality assurance procedures for both manufacturers and end‑users of all ready‑to‑use microbiological culture media, such as those in prepared plates, tubes, or bottles. The fundamental premise of M22-A3 is that retesting
media. Media used for antimicrobial susceptibility testing (AST) often follow separate guidelines, such as those found in under this standard or the physical inspection protocols it recommends?
CLSI M22-A3 is a document that provides guidelines for quality control in clinical microbiology laboratories. The document outlines best practices for ensuring the accuracy and reliability of laboratory results, which is critical for patient care. The guidelines cover various aspects of quality control, including: